GS
Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1351
Invitation Homes
INVH
$18.4B
|
CL
Chandni Luthra
| $30.01 | $35 |
17%
upside
| Neutral |
8 Dec ‘22
2 years ago |
|
1352
Nu Holdings
NU
$74.9B
|
MN
Michael Ng
| $15.51 | $9.50 |
39%
downside
| Buy |
6 Dec ‘22
2 years ago |
|
|
ZH
1353
Zhihu
ZH
$449M
|
LK
Lincoln Kong
| $5.12 | $12 |
134%
upside
| Neutral |
1 Dec ‘22
2 years ago |
|
1354
Bioventus
BVS
$468M
|
AH
Amit Hazan
| $7 | $2.50 |
64%
downside
| Neutral |
30 Nov ‘22
2 years ago |
|
1355
Vipshop
VIPS
$8.85B
|
RK
Ronald Keung
| $17.96 | $11.40 |
37%
downside
| Neutral |
23 Nov ‘22
2 years ago |
|
1356
The Beauty Health Co
SKIN
$292M
|
AH
Amit Hazan
| $2.30 | $19 |
726%
upside
| Buy |
23 Nov ‘22
2 years ago |
|
1357
Sotera Health
SHC
$4.47B
|
AH
Amit Hazan
| $15.74 | $8 |
49%
downside
| Neutral |
23 Nov ‘22
2 years ago |
|
1358
SEI Investments
SEIC
$10.7B
|
RB
Ryan Bailey
| $86.88 | $63 |
27%
downside
| Neutral |
23 Nov ‘22
2 years ago |
|
1359
Murphy Oil
MUR
$3.72B
|
BS
Brian Singer
| $26.07 | $50 |
92%
upside
| Neutral |
23 Nov ‘22
2 years ago |
|
1360
LivaNova
LIVN
$3.09B
|
AH
Amit Hazan
| $56.52 | $63 |
11%
upside
| Buy |
23 Nov ‘22
2 years ago |
|
1361
Becton Dickinson
BDX
$54B
|
AH
Amit Hazan
| $188.43 | $272 |
44%
upside
| Buy |
23 Nov ‘22
2 years ago |
|
1362
Bausch + Lomb
BLCO
$5.31B
|
AH
Amit Hazan
| $15 | $17 |
13%
upside
| Neutral |
23 Nov ‘22
2 years ago |
|
1363
Canadian Natural Resources
CNQ
$64.9B
|
NM
Neil Mehta
| $31.20 | $34.50 |
11%
upside
| Buy |
21 Nov ‘22
2 years ago |
|
|
CTEV
1364
Claritev Corporation
CTEV
$1.04B
|
CM
Cindy Motz
| $63.20 | $82 |
30%
upside
| Neutral |
16 Nov ‘22
2 years ago |
|
1365
Xometry
XMTR
$2.45B
|
ES
Eric Sheridan
| $48.31 | $57 |
18%
upside
| Buy |
14 Nov ‘22
2 years ago |
|
1366
Kanzhun
BZ
$11.2B
|
LK
Lincoln Kong
| $24.26 | $23 |
5%
downside
| Buy |
14 Nov ‘22
2 years ago |
|
1367
Prime Medicine
PRME
$693M
|
SR
Salveen Richter
| $3.89 | $22 |
466%
upside
| Neutral |
14 Nov ‘22
2 years ago |
|
1368
Dominion Energy
D
$50.7B
|
ML
Michael Lapides
| $59.42 | $69 |
16%
upside
| Neutral |
14 Nov ‘22
2 years ago |
|
1369
Rhythm Pharmaceuticals
RYTM
$6.66B
|
GS
Graig Suvannavejh
| $100.27 | $35 |
65%
downside
| Buy |
10 Nov ‘22
2 years ago |
|
1370
Precision BioSciences
DTIL
$59.1M
|
SR
Salveen Richter
| $5.01 | $30 |
499%
upside
| Neutral |
10 Nov ‘22
2 years ago |
|
1371
Kodiak Sciences
KOD
$513M
|
GS
Graig Suvannavejh
| $9.72 | $8 |
18%
downside
| Neutral |
10 Nov ‘22
2 years ago |
|
1372
Arcturus Therapeutics
ARCT
$489M
|
MK
Madhu Kumar
| $17.99 | $14 |
22%
downside
| Sell |
10 Nov ‘22
2 years ago |
|
1373
Sweetgreen
SG
$1.03B
|
JG
Jared Garber
| $8.69 | $21 |
142%
upside
| Buy |
9 Nov ‘22
2 years ago |
|
1374
Recursion Pharmaceuticals
RXRX
$1.98B
|
SR
Salveen Richter
| $4.54 | $9 |
98%
upside
| Neutral |
9 Nov ‘22
2 years ago |
|
1375
Outset Medical
OM
$241M
|
AH
Amit Hazan
| $13.54 | $435 |
3,113%
upside
| Buy |
9 Nov ‘22
2 years ago |
|